Home / Guides / Tirzepatide and alcohol
What the labels say. What to watch.
Tirzepatide and alcohol: can you drink, and what should you watch for?
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
Zepbound’s and Mounjaro’s labels (revised August 2026) don’t forbid alcohol; drinking may worsen nausea and reflux, and can drop blood sugar with insulin or sulfonylureas. Using tirzepatide to drink less is off-label and unproven: in a 2026 eBioMedicine study it cut drinking in rodents; compounded tirzepatide wasn’t studied.
- The labels: no alcohol limit or warning for Zepbound or Mounjaro
- With insulin or a sulfonylurea: lows are likelier, so eat first
- Drinking less: off-label and unproven; human trials are registered
Is it safe to drink alcohol on tirzepatide? The short answer
- On the labels
- No alcohol limit or warning, for Zepbound or Mounjaro
- Your stomach
- Alcohol may worsen nausea and reflux on a
GLP-1 - Low blood sugar
- Likelier with insulin or a sulfonylurea: eat when you drink
- Call right away
- Severe belly pain that won’t go away, or fluids that won’t stay down
- Drinking less
- Off-label and unproven; trials in people are registered
A question about drinking on your medicine? Call or text
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- The labels don’t forbid it. Zepbound’s and Mounjaro’s labels, revised August 2026, set no alcohol limit or warning.
- Your stomach may object. A 2025 advisory says to keep alcohol minimal on
GLP-1 medicines: it may worsen nausea and reflux. - On insulin or a sulfonylurea? MedlinePlus lists alcohol as a cause of lows, and tirzepatide with them raises the risk. Eat first.
- Go easy while your dose rises. Most nausea, vomiting and diarrhea in Zepbound’s trials came during dose increases.
- Drinking less isn’t an approved use. Tirzepatide cut drinking in rodents in a 2026 study; in people, it’s off-label and unproven.
- At NexLife, compounded tirzepatide is $115 a month on the 12-month plan. Drinking questions? Real people answer 24/7.
The labels
What do the Zepbound and Mounjaro labels say about alcohol?
No limit and no warning. Neither label mentions drinking in its warnings, interactions or side effects, and Zepbound’s patient guide doesn’t mention it either.
| Zepbound | Mounjaro | Compounded tirzepatide | |
|---|---|---|---|
| Made by | Eli Lilly | Eli Lilly | A state-licensed pharmacy, for one patient’s prescription |
| FDA-approved for | Weight reduction and keeping it off; moderate to severe sleep apnea with obesity (adults) | Type 2 diabetes, from age 10; lowering heart attack, stroke and heart-death risk in high-risk adults with it | Not FDA-approved |
| How you take it | A shot once a week: 2.5 mg to start, up to 15 mg | A shot once a week: 2.5 mg to start, up to 15 mg | Your prescription sets the dose and form |
| What it says about alcohol | No limit and no warning about drinking; benzyl alcohol is an inactive ingredient | No limit, and no warning in its warnings, interactions or side effects; benzyl alcohol is an inactive ingredient | No FDA label; your pharmacy label lists what’s in the vial |
| Low blood sugarglucose below 54 mg/dL | 4.2% vs 1.3% on placebo with type 2 diabetes (SURMOUNT-2, 2023); 0.3% vs none without (SURMOUNT-1, 2022) | 14% to 19% vs 13% on placebo with basal insulin (SURPASS-5, 2022); 0% vs 1% alone (SURPASS-1, 2021) | Not studied |
| Nauseaits most common side effect | 25% to 29% vs 8% on placebo (SURMOUNT-1 and SURMOUNT-2) | 12% to 18% vs 4% on placebo (SURPASS-1 and SURPASS-5) | Not studied |
| Pancreas and gallbladder | Warns about both; both were uncommon in its trials | Warns about both | Not studied |
Swipe the table sideways to see every column.
From the Zepbound and Mounjaro prescribing information (both revised August 2026) and Zepbound’s Medication Guide, read November 1, 2026. Percentages are by dose, against placebo, in the trials named. These trials studied FDA-approved Zepbound and Mounjaro; compounded tirzepatide wasn’t studied.
Silence isn’t a safety finding. A label lists what its trials measured and what the maker must warn about. What these labels do cover are the places to watch when you drink: stomach side effects, low blood sugar, the pancreas and fluid loss.
Your situation
Is drinking on tirzepatide OK for you? Start with your situation
It depends most on your other medicines, your dose step and your history. Your provider decides what’s safe for you.
You take insulin or a sulfonylurea
This is where alcohol needs the most care. Alcohol and these medicines can both cause low blood sugar, and tirzepatide adds to the risk. Never drink without eating, and ask your provider whether your diabetes doses should change.
You just started, or your dose just went up
In Zepbound’s trials, SURMOUNT-1 (2022) and SURMOUNT-2 (2023), most nausea, vomiting and diarrhea came while the dose was rising. That’s the time to skip alcohol or keep it very small.
You’ve had pancreatitis
Zepbound’s patient guide asks you to tell your provider if you have or have had pancreas problems. Tell them how much you drink, too. The labels don’t say whether alcohol changes tirzepatide’s pancreas risk, but heavy drinking is itself a common cause of pancreatitis, MedlinePlus says.
You drink most days, or want to cut back
Say so. Tirzepatide isn’t approved to treat alcohol use disorder, so using it that way is off-label. Your provider can talk you through care that’s made for it.
You’re eating much less
GLP-1 medicines cut how much people eat by 16% to 39% compared with placebo, a 2025 advisory says. A drink on a near-empty stomach is riskier with diabetes medicines, so have a meal first.You take compounded tirzepatide
It isn’t FDA-approved, has no FDA label and hasn’t been studied with alcohol. Follow your provider’s advice, and check your pharmacy label for anything added to the vial: what’s in compounded tirzepatide.
These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied. Your provider decides any change to your doses, tirzepatide or otherwise.
Your stomach
Does alcohol make tirzepatide side effects worse?
It can. A 2025 advisory from four medical and nutrition societies says alcohol may worsen nausea and reflux on
| Side effect | Zepbound, 5 mg to 15 mg | Placebo |
|---|---|---|
| Nausea | 25% to 29% | 8% |
| Diarrhea | 19% to 23% | 8% |
| Vomiting | 8% to 13% | 2% |
| Indigestiondyspepsia | 9% to 10% | 4% |
| Acid refluxGERD | 4% to 5% | 2% |
Swipe the table sideways to see every column.
Share of adults reporting each, in SURMOUNT-1 (2022) and SURMOUNT-2 (2023), two 72-week trials pooled: 958 people on placebo and 2,519 on Zepbound. Zepbound prescribing information (revised August 2026), Table 1. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
Why your stomach is the weak spot. Stomach side effects are tirzepatide’s most common. In the same trials, 56% of people had one at each dose, versus 30% on placebo, and most nausea, vomiting and diarrhea came during dose increases, then eased. Compounded tirzepatide wasn’t studied.
Fluids matter more when you’re sick. Diarrhea, nausea and vomiting can dehydrate you, and Zepbound’s patient guide warns that dehydration can lead to kidney problems. If drinking leaves you vomiting, that’s fluid lost on top. Sip fluids, and tell your provider right away if nausea, vomiting or diarrhea doesn’t go away.
More on easing nausea: tirzepatide side effects and what to eat on a
In their words
When should you go easiest on alcohol while taking tirzepatide?
While your dose is rising, skip alcohol or keep it very small, because Zepbound’s label reports:
“The majority of nausea, vomiting, and/or diarrhea events occurred during dose escalation and decreased over time.”
Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026
Low blood sugar
Can alcohol cause low blood sugar on tirzepatide?
Yes, mainly if you also take insulin or a sulfonylurea. MedlinePlus lists alcohol as a cause of lows in people on those medicines, and tirzepatide’s labels say taking it with them raises the risk.
“ZEPBOUND lowers blood glucose and can cause hypoglycemia.”
| Trial | Who took part | Low blood sugar on tirzepatide | On placebo |
|---|---|---|---|
| SURPASS-1Mounjaro, 2021, 40 weeks | Type 2 diabetes, no other diabetes medicine | 0% at 5, 10 or 15 mg | 1% |
| SURPASS-5Mounjaro, 2022, 40 weeks | Type 2 diabetes, on basal insulin | 14% to 19%; severe in up to 2% | 13%; severe in none |
| SURMOUNT-2Zepbound, 2023, 72 weeks | Type 2 diabetes, BMI 27 or more | 4.2% | 1.3% |
| SURMOUNT-1Zepbound, 2022, 72 weeks | No diabetes | 0.3% (lows weren’t tracked closely) | None |
Swipe the table sideways to see every column.
Low blood sugar here means glucose below 54 mg/dL. From the Mounjaro prescribing information (Table 2) and the Zepbound prescribing information (section 6.1), both revised August 2026. These trials studied FDA-approved Zepbound and Mounjaro; compounded tirzepatide wasn’t studied.
Where alcohol comes in. MedlinePlus, the National Library of Medicine’s health site, lists drinking alcohol as a cause of low blood sugar in people with diabetes who take insulin or pills such as glyburide, glipizide or glimepiride. Its advice: don’t drink without eating, and keep it to 1 drink a day for women or 2 for men.
Know the signs. Zepbound’s patient guide lists dizziness, blurred vision, sweating, shakiness, hunger, confusion or drowsiness, weakness, a headache and a fast heartbeat, among others. If you take insulin or a sulfonylurea, check your blood sugar when you feel any of them. Tired often, even on days you don’t drink? See why tirzepatide can make you tired.
Lows can come later. Low blood sugar can strike hours after your last drink, and its signs can look like being drunk, the American Diabetes Association says. If you take insulin or a sulfonylurea, tell the people you’re with; MedlinePlus says family and friends should know how to help.
If it’s low. MedlinePlus’s rule for a reading under 70 mg/dL: have about 15 grams of carbohydrate, such as juice or glucose tablets, wait about 15 minutes, then check again. Get medical help right away for anyone who isn’t alert or can’t be woken up, and don’t drive while your blood sugar is low.
No diabetes? Lows were rare in SURMOUNT-1, but Zepbound’s label says they’ve been seen in adults without type 2 diabetes too. Compounded tirzepatide wasn’t studied.
Ask before you change anything. The labels say a lower dose of insulin or a sulfonylurea may reduce the risk. Only your provider should change those doses.
Pancreas and gallbladder
Does drinking on tirzepatide raise the risk of pancreatitis or gallbladder problems?
The labels don’t say, because they don’t mention alcohol. But heavy drinking is itself a common cause of pancreatitis, and the labels warn about pancreatitis and gallbladder problems, so the signs are worth knowing.
| In Zepbound’s weight trials | Zepbound | Placebo |
|---|---|---|
| Pancreatitisconfirmed by a review panel | 0.2% | 0.2% |
| Gallstonescholelithiasis | 1.1% | 1% |
| Inflamed gallbladdercholecystitis | 0.7% | 0.2% |
| Gallbladder removedcholecystectomy | 0.2% | None |
Swipe the table sideways to see every column.
SURMOUNT-1 (2022) and SURMOUNT-2 (2023), pooled, from the Zepbound prescribing information, section 6.1, revised August 2026. In the two sleep apnea trials (SURMOUNT-OSA, 2024), confirmed pancreatitis ran at 0.84 people per 100 years of treatment on Zepbound and none on placebo. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied.
Pancreatitis signs. Stop tirzepatide and call your provider right away for severe pain in your stomach area that won’t go away, with or without nausea or vomiting. Zepbound’s patient guide says the pain can reach your back.
Gallbladder signs. Tell your provider right away about pain in your upper stomach, yellowing skin or eyes, a fever or clay-colored stools.
Had pancreas problems before? The patient guide asks you to tell your provider before you start. Mention how much you drink in the same conversation, so they can weigh it with your history.
Cravings
Does tirzepatide reduce alcohol cravings?
Maybe, but it isn’t proven in people. Tirzepatide reduced drinking in rats and mice in a 2026 eBioMedicine study, trials in people are registered, and using it for alcohol use disorder is off-label. Compounded tirzepatide wasn’t studied.
| Study | What it found | What it can’t tell you |
|---|---|---|
| Tirzepatide in rats and miceeBioMedicine, January 2026 | The animals drank less as the dose rose, and it prevented binge and relapse-like drinking in the tests used. It also dulled alcohol’s dopamine reward. | Whether it works the same way in people |
| Semaglutide in 48 adults with alcohol use disorderJAMA Psychiatry, 2025 | Nine weeks of low doses cut some, but not all, measures of drinking and craving, as a 2025 advisory sums it up. Smokers in the trial smoked less. | Whether tirzepatide does the same; the trial was small and short |
| Doctors’ experience2025 joint advisory | The advisory’s authors say that in their clinical practice, cravings for high-fat foods, sugary foods and alcohol are diminished on | It’s clinical experience, not a trial |
| Tirzepatide in peopleUSC’s TAOS trial, NCT06994338 | Lists 2026 as its recruitment period, for adults 21 to 65 who want to cut back or quit drinking, over 12 weeks. | Anything, until it reports |
Swipe the table sideways to see every column.
From the eBioMedicine paper’s abstract (published January 7, 2026), the University of Gothenburg’s release (February 19, 2026), the 2025 joint advisory of four medical and nutrition societies (which summarizes the semaglutide trial) and the University of Southern California’s trial listing, all read November 1, 2026. None of these is an approval, and none studied compounded tirzepatide.
Off-label, plainly. Zepbound is approved for weight and sleep apnea, and Mounjaro for type 2 diabetes. Neither label lists alcohol use disorder, so prescribing tirzepatide to drink less is off-label.
More trials are registered. ClinicalTrials.gov also lists NCT06727331, a study of tirzepatide for recovery and alcohol use management, and NCT06939088, on tirzepatide and drinking in people with schizophrenia and alcohol use disorder.
If you want to drink less, tell your provider. Tirzepatide isn’t a treatment for alcohol use disorder, and your provider can talk you through care that is. If you’re in distress, call or text 988, any time; it’s free. For free, confidential help finding treatment for alcohol use, call SAMHSA’s National Helpline at 1-800-662-HELP (4357), 24 hours a day, in English or Spanish.
Timing
How long after a tirzepatide shot can you drink?
There’s no label rule on timing, and waiting a day or two doesn’t clear it. Tirzepatide’s half-life is about 5 days, so it’s working all week.
“Tirzepatide delays gastric emptying.”
| How long it lasts | Its half-life is about 5 days on Mounjaro’s label and 5 to 6 days on Zepbound’s, which is why it’s a weekly shot. About half of a dose is still in your body 5 days later. |
|---|---|
| Shot day vs. other days | The labels don’t tie any risk to the day of the week, so no day of the week is safer than another for a drink. |
| Missed a dose? | Zepbound’s guide says take it within 4 days; after that, skip it and take the next on your usual day. Never take 2 doses within 3 days of each other. |
| Slower stomach emptying | Tirzepatide delays how fast your stomach empties, and that can change how pills you swallow are absorbed. The label says the effect eases over time. |
Will you feel drinks more? No study in the labels measured it, and no label says how slower stomach emptying changes alcohol. Drink slowly, see how you feel, and plan a ride home.
Don’t move or skip a dose to make room for a drink. After a longer break, your provider may restart you at a lower dose: restarting tirzepatide after a break.
Drinking safer
How do you drink more safely on tirzepatide?
Eat first, keep it small and go easiest while your dose is rising. Your provider decides what’s right for you.
Tell your provider
Say how much and how often you drink. It shapes their advice on your dose steps and your other medicines.
Eat first
Have a meal before or while you drink. If you take insulin or a sulfonylurea, MedlinePlus says not to drink without food at all.
Keep it small
The 2025 advisory says to keep alcohol to a minimum on a
GLP-1. For people with diabetes, MedlinePlus sets the top limit at 1 drink a day for women and 2 for men.Go easy during dose steps
Doses rise no faster than every 4 weeks, and the rising weeks are when most stomach side effects showed up in SURMOUNT-1 (2022) and SURMOUNT-2 (2023). Until your dose settles, skip drinks or keep them very small.
Keep water close
Fluids help prevent dehydration, Zepbound’s patient guide says. That matters most when you’re vomiting or have diarrhea.
Check your blood sugar
On insulin or a sulfonylurea? Check when you feel shaky, sweaty, dizzy or confused. Under 70 mg/dL, have 15 grams of carbohydrate and check again in 15 minutes.
The six steps above, in order. Your prescriber’s instructions and your medicine’s label come first.
From Zepbound’s Medication Guide (revised August 2026), MedlinePlus’s low blood sugar guidance (reviewed January 25, 2026) and the 2025 joint advisory. These trials studied FDA-approved Zepbound; compounded tirzepatide wasn’t studied. More on food: what to eat on a
Dose steps
What are tirzepatide’s dose steps, in mL and units?
Both labels start at 2.5 mg once a week and go up to 15 mg. Doses rise no faster than every 4 weeks, and most stomach side effects came during those rises. The table shows each dose at 25 mg per mL, as an example only.
| Dose | Volume at 25 mg/mL | Units (U-100) |
|---|---|---|
| 2.5 mg | 0.1 mL | 10 units |
| 5 mg | 0.2 mL | 20 units |
| 7.5 mg | 0.3 mL | 30 units |
| 10 mg | 0.4 mL | 40 units |
| 12.5 mg | 0.5 mL | 50 units |
| 15 mg | 0.6 mL | 60 units |
Example only. The math: mL = your dose in mg ÷ your vial’s strength in mg per mL, and units = mL × 100 on a U-100 syringe. Zepbound’s multi-dose vials hold each dose in 0.6 mL, so only its 15 mg vial is 25 mg per mL; other vials differ, and your vial’s label decides. Your provider sets your dose and when it changes. Drew more than your dose? Here’s what to do if you took too much tirzepatide. Or enter your own vial’s strength in the tirzepatide dosage calculator.
Get help
When should you get help after drinking on tirzepatide?
Some symptoms need a call to your provider right away, and a few need 911. Here’s which is which.
Call 911 for trouble breathing or swallowing, swelling of your face, lips, tongue or throat, fainting, confusion, a seizure, blood in your vomit, or anyone who isn’t alert or can’t be woken up.
| If you notice | It can be a sign of | What to do |
|---|---|---|
| Severe belly pain that won’t go awayit may spread to your back | Pancreatitis | Stop tirzepatide and call your provider right away |
| Vomiting for more than a day, or no fluids kept down for 12 hours | Dehydration, which can lead to kidney problems | Contact your provider right away, or get care |
| Blood or dark, coffee-colored material in your vomit | A medical emergency | Call 911 or go to an emergency room |
| Very dark urine or almost none, dizziness, a racing heart | Severe dehydration | Get care now; call 911 if confusion or fainting sets in |
| Shakiness, sweating, hunger or confusionif you take insulin or a sulfonylurea | Low blood sugar | Check it; under 70 mg/dL, have 15 grams of carbohydrate and check again in 15 minutes |
| Upper belly pain, fever, yellow skin or eyes, clay-colored stools | A gallbladder problem | Tell your provider right away |
| A severe rash or itching, or a very fast heartbeatwith or without swelling | A serious allergic reaction | Stop tirzepatide and get medical help right away |
| Sudden, painless vision loss in one eyeor blind spots, tunnel vision or faded colors | NAION, a rare optic nerve problem the FDA warned about on Nov. 9, 2026 (more) | Call your provider right away |
Swipe the table sideways to see every column.
From Zepbound’s Medication Guide (revised August 2026) and MedlinePlus (dehydration, reviewed July 1, 2025; nausea and vomiting, July 22, 2025; low blood sugar, January 25, 2026), and the FDA’s Nov. 9, 2026, NAION safety communication. If your provider tells you something different, follow their instructions.
Report it. You or your provider can report a side effect to the FDA at
Cost
What does tirzepatide cost in 2026, every way to pay?
From $50 a month on Medicare’s Bridge, if you qualify, to $449–$699 for Zepbound from 7.5 mg at LillyDirect (depending on refill timing) and $499 for Mounjaro. Here’s each route: brand-name prices checked Nov. 1, 2026, and compounded prices Nov. 4, 2026.
| How you pay | What you pay | Good to know |
|---|---|---|
| Insuranceif your plan covers it | Your plan’s copay | Zepbound’s savings card can bring a covered pen to as little as $25 for a 1- to 3-month fill. It ends December 31, 2026 and isn’t for Medicare or Medicaid |
| Zepbound at LillyDirectKwikPen or vials, self-pay | $299 at 2.5 mg, $399 at 5 mg, $449 from 7.5 mg | Refill within 45 days, or 7.5 mg and up costs $499 to $699. A month is 28 days |
| Mounjaro at LillyDirectself-pay | $499 a month at every dose | Approved for type 2 diabetes |
| TrumpRx.govZepbound vials | Starting at $299 | An out-of-pocket price; Lilly fills the order through LillyDirect |
| Medicare | $50 a month | Zepbound KwikPen, with prior authorization, through December 31, 2027. Not for type 2 diabetes, moderate to severe sleep apnea or fatty liver disease, which Part D may cover instead |
| Compounded tirzepatide online25 programs that publish a month-to-month price, all in | $126 to $599 a month in our price index (median $285) | Not FDA-approved. Checked Nov. 4, 2026 |
| NexLife,compounded tirzepatide, not FDA-approved | $115 a month on the 12-month plan | $129 month to month; the same price at every dose, with no membership fee |
Swipe the table sideways to see every column.
Prices from LillyDirect, Lilly’s savings card terms, TrumpRx.gov, CMS and Medicare.gov, checked November 1, 2026. Compounded prices from our
NexLife Price Match Guarantee†. Already on compounded tirzepatide with another licensed provider, and paying less? We match your regular monthly price. How it works
The yearly gap. At $449 a month from 7.5 mg, with a refill within 45 days each time (otherwise $499 at 7.5 mg and $699 at 10 to 15 mg), a year of Zepbound from LillyDirect is 13 four-week fills: $5,837. Compounded tirzepatide at NexLife, which isn’t FDA-approved, is $1,380 a year on the 12-month plan, or $1,548 month to month. It isn’t Zepbound, and a licensed provider decides if it’s right for you.
Have type 2 diabetes? NexLife’s providers prescribe compounded tirzepatide for weight loss. It isn’t a treatment for type 2 diabetes and doesn’t replace Mounjaro or your diabetes care.
Paying less elsewhere for compounded tirzepatide? Our Price Match Guarantee† matches your regular monthly price. More: Zepbound’s cost without insurance and who qualifies for the Medicare Bridge.
At NexLife
Drinking and tirzepatide at NexLife: who helps, and what you pay
Care and access, not a promise: anyone on tirzepatide can have side effects, drink or not. Here’s who helps.
Tell a licensed provider the whole story
A licensed provider reviews your health history and prescribes only if compounded tirzepatide is right for you: online, following your state’s rules. Include how you drink.
Call or text, any time
Reach us at
(949) 818-8000 . Real people answer 24/7, and physicians answer medical questions during clinical hours. Our medical director, Adam Kennah, MD, is board-certified in emergency medicine by the American Board of Emergency Medicine. For an emergency, call 911.A provider who follows your dose
If side effects make a dose step hard, your provider decides whether to hold it or lower your dose. Your price stays the same either way.
Help with food
Every plan includes a nutrition plan and a 1:1 coaching call.
We handle the pharmacy
A state-licensed 503A partner pharmacy fills your prescription: Absolute Pharmacy in Lutz, FL, or Boudreaux’s New Drug Store in Lake Charles, LA. Questions about your order come to us, and shipping is free and expedited.
One price at every dose
$115 a month on the 12-month plan, $119 on 6 months, $125 on 3 months or $129 month to month, with no membership fee. Pay with an HSA or FSA card (we provide a letter of medical necessity) or Affirm, Klarna or Afterpay. Not prescribed? No charge for medication. Compounded tirzepatide isn’t FDA-approved, isn’t Zepbound or Mounjaro, and a licensed provider prescribes it only when it offers a significant difference for you.
NexLife is LegitScript-certified and rated 4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 1, 2026).
What does NexLife cost?
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $115/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $129/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication

12-month plan $95/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Paying less elsewhere?
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Tirzepatide and alcohol: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
Can you drink alcohol while taking tirzepatide?
Zepbound’s and Mounjaro’s labels (revised August 2026) don’t forbid alcohol; drinking may worsen nausea and reflux, and can drop blood sugar with insulin or sulfonylureas. Talk with your provider about how much you drink, especially if you take insulin or a sulfonylurea, or your dose just went up.
How long after a tirzepatide shot can you drink alcohol?
There’s no label rule on timing. Tirzepatide’s half-life is about 5 days, so it’s active all week, and waiting a day or two after your shot doesn’t clear it. Don’t skip or move a dose to drink: if you miss one, Zepbound’s guide says take it within 4 days, or skip it.
Does alcohol make tirzepatide side effects worse?
It can: a 2025 advisory from four medical and nutrition societies says alcohol may worsen nausea and reflux on
Can drinking alcohol on tirzepatide cause low blood sugar?
Yes, mostly if you also take insulin or a sulfonylurea. MedlinePlus lists alcohol as a cause of low blood sugar in people on those medicines, and tirzepatide’s labels say taking it with them raises the risk. Don’t drink without eating, and check your blood sugar if you feel shaky, sweaty or confused.
Does drinking on tirzepatide raise the risk of pancreatitis?
The labels don’t say: they don’t mention alcohol. But heavy drinking is itself a common cause of pancreatitis: MedlinePlus says alcohol use causes 17% to 25% of acute cases in the U.S. If you’ve had pancreatitis or drink heavily, tell your provider first. Stop tirzepatide and call your provider right away for severe belly pain that won’t go away.
Does tirzepatide reduce alcohol cravings?
It might, but that isn’t proven in people, and using tirzepatide to drink less is off-label. In a 2026 eBioMedicine study, tirzepatide reduced drinking and relapse-like drinking in rats and mice. A small 2025 semaglutide trial (JAMA Psychiatry) cut some, but not all, measures of drinking. Human trials are registered; compounded tirzepatide wasn’t studied.
Is tirzepatide approved to treat alcohol use disorder?
No. Zepbound is approved for weight reduction and sleep apnea, and Mounjaro for type 2 diabetes. Neither label lists alcohol use disorder, so using tirzepatide to drink less is off-label. If drinking worries you, tell your provider, and in distress, call or text 988 any time.
Do you feel alcohol more on Zepbound or Mounjaro?
The labels can’t say: they report no alcohol studies. Tirzepatide does slow how fast your stomach empties, an effect that fades over time, and that can change how pills are absorbed. So drink slowly, eat first, see how you feel and don’t drive.
Does alcohol stop tirzepatide from working?
Neither label says it does. Drinks do add calories, though, and a 2025 advisory on
Is compounded tirzepatide different with alcohol?
No one knows: compounded tirzepatide isn’t FDA-approved and hasn’t been studied with alcohol, or in the trials behind Zepbound and Mounjaro. Follow the same cautions and your provider’s advice, and check your pharmacy label for anything added. Questions? Call or text NexLife at
How much alcohol can you drink on tirzepatide?
The labels set no limit, but a 2025 advisory says to keep alcohol to a minimum on GLP-1 medicines. For people with diabetes, MedlinePlus sets the top limit at 1 drink a day for women and 2 for men. If you take insulin or a sulfonylurea, don’t drink without food.
Can drinking on tirzepatide dehydrate you?
It can if drinking makes you sick. Diarrhea, nausea and vomiting can dehydrate you, and Zepbound’s patient guide warns that dehydration can lead to kidney problems. Sip fluids, and contact your provider right away if vomiting lasts more than a day or you can’t keep fluids down for 12 hours.
What should you do if your blood sugar drops after drinking on tirzepatide?
Follow MedlinePlus’s rule for a reading under 70 mg/dL: have about 15 grams of carbohydrate, such as juice or glucose tablets, wait about 15 minutes, then check again. Get medical help right away for anyone who isn’t alert or can’t be woken up, and don’t drive while your blood sugar is low.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Checked every label fact, price and study against its source on Nov. 1, 2026; compounded prices against our price index on Nov. 4, 2026; and the NAION warning against the FDA’s Nov. 9, 2026, safety communication, read Nov. 12, 2026.
- How we checked. What the labels say comes from the Zepbound and Mounjaro prescribing information (both revised August 2026) and Zepbound’s Medication Guide, read on November 1, 2026. The low blood sugar, pancreatitis, dehydration and nausea guidance comes from MedlinePlus and the American Diabetes Association, the help line from SAMHSA, the eating advice from a 2025 joint advisory of four medical and nutrition societies, the research from the eBioMedicine paper, the University of Gothenburg and the University of Southern California, and the prices from LillyDirect, TrumpRx.gov, CMS and Medicare.gov, all read the same day. Compounded prices come from our GLP-1 price index, checked Nov. 4, 2026, and the NAION warning from the FDA’s Nov. 9, 2026, safety communication, read Nov. 12, 2026. We don’t give a dosing plan: your provider decides. Zepbound, Mounjaro, KwikPen and LillyDirect are trademarks of Eli Lilly and Company. NexLife isn’t affiliated with Eli Lilly and Company.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email hello@nexlife.us and we’ll fix it.
- How we work. How we review programs · GLP-1 price index · Is NexLife legit? · States NexLife serves
Paying less elsewhere? We match it.†
Questions about drinking on your medicine? Real people answer 24/7.
Start with a 3-minute online check. A licensed provider decides if compounded tirzepatide is right for you, and the price is the same at every dose: $115 a month on the 12-month plan, or $129 month to month.
4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 1, 2026) · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, following your state’s rules. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- Zepbound (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 1, 2026.
- Zepbound prescribing information, PDF (revised August 2026). Read November 1, 2026.
- Zepbound Medication Guide, Eli Lilly (revised August 2026). Read November 1, 2026.
- Mounjaro (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 1, 2026.
- Eli Lilly: Zepbound dosing, for healthcare professionals (names SURMOUNT-1 and SURMOUNT-2). Read November 1, 2026.
- SURMOUNT-2: Garvey WT, et al. The Lancet 2023;402:613-26. Citation checked October 25, 2026.
- SURPASS-1: Rosenstock J, et al. The Lancet 2021;398:143-55 (American College of Cardiology trial summary). Read November 1, 2026.
- SURPASS-5: Dahl D, et al. JAMA 2022;327(6):534-545. Read October 25, 2026.
- Mozaffarian D, et al. Nutritional priorities to support
GLP-1 therapy for obesity: a joint advisory. Obesity, 2025;33(8):1475-1503. Read November 1, 2026. - Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents. eBioMedicine 2026;124:106119 (January 7, 2026). Abstract read November 1, 2026.
- University of Gothenburg: Reduced alcohol consumption with Mounjaro’s active substance (February 19, 2026). Read November 1, 2026.
- Hendershot CS, et al. Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry 2025;82:395-405. As summarized in the 2025 joint advisory.
- Keck Medicine of USC: Tirzepatide Alcohol Outcomes Study (TAOS), NCT06994338. Checked October 25, 2026.
- ClinicalTrials.gov: NCT06727331, tirzepatide for recovery and alcohol use management. Title checked October 25, 2026.
- ClinicalTrials.gov: NCT06939088, tirzepatide and alcohol intake in schizophrenia and alcohol use disorder. Title checked October 25, 2026.
- MedlinePlus: Low blood sugar, self-care (reviewed January 25, 2026). Read November 1, 2026.
- MedlinePlus: Low blood sugar (reviewed January 25, 2026). Read November 1, 2026.
- MedlinePlus: Dehydration (reviewed July 1, 2025). Read November 1, 2026.
- MedlinePlus: Nausea and vomiting, adults (reviewed July 22, 2025). Read November 1, 2026.
- MedlinePlus: Acute pancreatitis (reviewed October 20, 2025). Read November 1, 2026.
- American Diabetes Association: Alcohol and diabetes. Read November 1, 2026.
- SAMHSA: National Helpline, 1-800-662-HELP (4357). Read October 25, 2026.
- FDA Drug Safety Communication on
GLP-1 medicines and suicidal thoughts (January 13, 2026; 988 crisis line). Read November 1, 2026. - LillyDirect: Zepbound self-pay prices. Checked November 1, 2026.
- LillyDirect: Mounjaro self-pay prices. Checked November 1, 2026.
- Eli Lilly: Zepbound savings card terms. Checked November 1, 2026.
- TrumpRx.gov: Zepbound vial. Checked November 1, 2026.
- CMS: Medicare
GLP-1 Bridge. Checked November 1, 2026. - Medicare.gov: Weight loss drugs (the
GLP-1 Bridge). Checked November 1, 2026. - NexLife:
GLP-1 price index. Compounded prices checked Nov. 4, 2026. - NexLife: pricing, every plan.